Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy

Publisher： Bentham Science Publishers

E-ISSN： 2212-6988|1|1|40-53

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.1, Iss.1, 2013-12, pp. : 40-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 40-53

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

By  

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Effects of Multiple Flavonoids on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport

By Zhang Shuzhong   Yang Xinning   Morris Marilyn E.  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1263-1273

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Organic Isothiocyanates on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport

By Ji Yan   Morris Marilyn E.  

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2261-2269

Springer Publishing Company

Access to resources Recommend Favorite